Amarantus To Present Poster on Alzheimer’s Blood Assay At 12th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders

Amarantus To Present Poster on Alzheimer’s Blood Assay At 12th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
amarantus-bigAmarantus, a biotechnology company developing diagnostics in neurology and orphan drugs in neurology, ophthalmology, psychiatry and regenerative medicine, recently announced their abstract "The LymPro® Assay: A Biomarker For Alzheimer's Disease Using Blood Samples From Clinically Diagnosed Alzheimer's Disease And Cognitively Intact Subjects" has been accepted for poster presentation at the 12th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders. The conference will be held in Nice, France on March 18-22, 2015. The poster will be presented by Louis Kirby, Amarantus' representative. The poster will cover positive blood sample analyses of 140 individuals using Amarantus' LymPro Test, a blood-based assay indicated for Alzheimer's disease. Enrollees in the LymPro Test's clinical trial included 71 Alzheimer's patients and 69 controls without the disease, all within the same age range. The company's test measures th
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *